Kumar A, Dutt M, Dehury B, Sganzerla Martinez G, Swan CL, Kelvin A, Richardson C, Kelvin DJ.
Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.
Journal of Biomolecular Structure and Dynamics 2023. [Link]

Karuhije J, Nkeshimana M, Zakham F, Hewins B, Rutayisire J, Sganzerla Martinez G, Kelvin DJ, Ndishimye P
Understanding knowledge, attitudes and practices on Ebola Virus Disease: a multi-site mixed methods survey on preparedness in Rwanda.
BMC Public Health, 2023, (23) 2417. [Link]

Sganzerla Martinez G, Dutt M, Kumar A, Kelvin DJ.
PoxiPred: An artificial intelligence-based method for the prediction of potential antigens and epitopes to accelerate vaccine development efforts against poxviruses.
(PREPRINT) Biorxiv (2023) [Link]

Sganzerla Martinez G, Kelvin DJ.
Convergence in Mobility DataSets from Apple, Google, and Meta.
JMIR Public Health and Surveillance, 2023;9:e44286. [Link]

Dutt M, Kumar A, Rout M, Dehury B, Sganzerla Martinez G, Ndishimye P, Kelvin AA, Kelvin DJ.
Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Journal of Cellular Biochemistry, 2023, 24:701-715. [Link]

Sganzerla Martinez G, Hewins B, LeBlanc JJ, Ndishimye P, Ostadgavahi AT, Kelvin DJ.
Evaluating the effectiveness of lockdowns and restrictions during SARS-CoV-2 variant waves in the Canadian province of Nova Scotia.
Frontiers in Public Health, 2023, 11. [Link]

Shukla R, Chandra A, Kumar A, Kandpal P, Avashthi H, Goel VK, Qamar I, Singh N, Kelvin DJ, Singh TR.
Repurposing of drugs against methyltransferase as potential Zika virus therapies
Scientif Reports 2023, 13 (7870). [Link]

Garduno A, Sganzerla Martinez G, Ostadgavahi AT, Kelvin DJ, Cusack R, Martin-Loeches I.
Parallel Dysregulated Immune Response in Severe Forms of COVID-19 and Bacterial Sepsis via Single-Cell Transcriptome Sequencing.
Biomedicines 2023, 11(3). [Link]

Sganzerla Martinez G, Ostadgavahi AT, Mahmud-Al-Rafat A, Garduno A, Cusack R, Bermejo-Martin JF, Martin-Loeches I, Kelvin DJ.
Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU.
Frontiers in Immunology, 2023, 14. [Link]

Shukla R, Kumar A, Kelvin DJ, Singh TR.
Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer’s disease: An integrative molecular modeling approach.
Frontiers in Molecular Biosciences, 2023, 9. [Link]

Sganzerla Martinez G, Garduno A, Mahmud-Al-Rafat A, Ostadgavahi AT, Avery A, de Avila e Silva S, Cusack R, Cameron C, Cameron M, Martin-Loeches I, Kelvin DJ.
An artificial neural network classification method employing longitudinally monitored immune biomarkers to predict the clinical outcome of critically ill COVID-19 patients.
PeerJ, 2022, 10:e14487. [Link]

Kumar A, Sharma M, Richardson CD, Kelvin DJ.
Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach
Frontiers in Molecular Biosciences, 2022, 9. [Link]

Hewins B, Rahman M, Bermejo-Martin JF, Kelvin AA, Richardson CD, Rubino S, Kumar A, Ndishimye P, Ostadgavahi AT, Mahmud-Al-Rafat, A, Kelvin DJ.
Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch.
Frontiers in Virology, 2022, 2. [Link]